Livedoid vasculopathy: experience in using rituximab

Saved in:
Bibliographic Details
Main Authors: Tatyana Valentinovna Beketova, S K Solovyev, S G Radenska-Lopovok, E L Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2011-08-01
Series:Научно-практическая ревматология
Online Access:https://rsp.mediar-press.net/rsp/article/view/350
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849688815911829504
author Tatyana Valentinovna Beketova
S K Solovyev,
S G Radenska-Lopovok
E L Nasonov
author_facet Tatyana Valentinovna Beketova
S K Solovyev,
S G Radenska-Lopovok
E L Nasonov
author_sort Tatyana Valentinovna Beketova
collection DOAJ
format Article
id doaj-art-79c4c606429846e5921b00ddd27f6ef2
institution DOAJ
issn 1995-4484
1995-4492
language Russian
publishDate 2011-08-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-79c4c606429846e5921b00ddd27f6ef22025-08-20T03:21:51ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922011-08-01494788110.14412/1995-4484-2011-66290Livedoid vasculopathy: experience in using rituximabTatyana Valentinovna BeketovaS K Solovyev,S G Radenska-LopovokE L Nasonovhttps://rsp.mediar-press.net/rsp/article/view/350
spellingShingle Tatyana Valentinovna Beketova
S K Solovyev,
S G Radenska-Lopovok
E L Nasonov
Livedoid vasculopathy: experience in using rituximab
Научно-практическая ревматология
title Livedoid vasculopathy: experience in using rituximab
title_full Livedoid vasculopathy: experience in using rituximab
title_fullStr Livedoid vasculopathy: experience in using rituximab
title_full_unstemmed Livedoid vasculopathy: experience in using rituximab
title_short Livedoid vasculopathy: experience in using rituximab
title_sort livedoid vasculopathy experience in using rituximab
url https://rsp.mediar-press.net/rsp/article/view/350
work_keys_str_mv AT tatyanavalentinovnabeketova livedoidvasculopathyexperienceinusingrituximab
AT sksolovyev livedoidvasculopathyexperienceinusingrituximab
AT sgradenskalopovok livedoidvasculopathyexperienceinusingrituximab
AT elnasonov livedoidvasculopathyexperienceinusingrituximab